Factbox: Trump's tariffs and threatened trade actions
Brief: Astellas Pharma, Yaskawa Electric: Agree To Establish Joint Venture Focused On Cell Therapy Manufacturing
Factbox: Trump's tariffs and threatened trade actions
Factbox: All of Trump's tariffs and threatened trade actions
Factbox: All of Donald Trump's tariffs and threatened trade actions
Brief: Astellas Pharma Inc - U.S. FDA Approves Expanded Label For Astellas' Izervay(Avacincaptad Pegol Intravitreal Solution) For Geographic Atrophy
Brief: Farallon Capital Management Has Built More Than 3% Position In Astellas - FT
Farallon Capital builds over 3% stake in Japan's Astellas, FT reports
Brief: Pfizer And Astellas’ Padcev Plus Keytruda Shows Long-Term Efficacy In First-Line Treatment Of Locally Advanced Or Metastatic Urothelial Cancer
Factbox: All of Donald Trump's tariffs and threatened trade actions
Brief: Astellas Pharma Inc- Recording Of Extraordinary Losses In Non-Consolidated Financial Results
Table: Astellas -9-MTH group results (IFRS)
Factbox: All of Donald Trump's tariff threats
Factbox: All of Donald Trump's tariff threats
Explainer: Trump tariffs on chips and drugs would hit U.S. allies in Asia
Brief: Astellas Pharma Inc- Notice Regarding Progress In Core Business, Impairment Loss And Revision Of Financial Forecasts For Fy2024
Table: Astellas -2024/25 group forecast(IFRS)
Brief: Sangamo Therapeutics & Astellas Enter Capsid License Agreement
Brief: EMA’s PRAC Says Insufficient Evidence to Link Doxycycline To Suicidality Risk